awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38030595-1495D468-C097-4777-8C4C-31FA5A24B46F
Q38030595-1495D468-C097-4777-8C4C-31FA5A24B46F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38030595-1495D468-C097-4777-8C4C-31FA5A24B46F
Current and emerging treatments in the management of castration-resistant prostate cancer.
P2860
Q38030595-1495D468-C097-4777-8C4C-31FA5A24B46F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38030595-1495D468-C097-4777-8C4C-31FA5A24B46F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ed2561e39cd7989abdcb7bb548a4030b96484e6
P2860
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.